Adult Onset Growth Hormone Deficiency Completed Phase 3 Trials for Somatotropin (DB00052)

Also known as: Growth Hormone Deficiency, Adult / Adult-Onset Growth Hormone Deficiency / Adult Growth Hormone Deficiency (AGHD) / Adult Growth Hormone Deficiency / Adults Growth Hormone Deficiency / Adult-onset growth hormone deficiency (disorder) / Adult growth hormone deficiency (disorder)

IndicationStatusPhase
DBCOND0072078 (Adult Onset Growth Hormone Deficiency)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03075644A Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-0092) and Daily Norditropin® FlexPro® for 52 Weeks in Previously Human Growth Hormone Treated Japanese Adults With Growth Hormone DeficiencyTreatment
NCT02382939A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone DeficiencyTreatment
NCT02229851Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Placebo and Norditropin® FlexPro® (Somatropin) in Adults With Growth Hormone Deficiency.Treatment
NCT00596037Treatment of Adults With Growth Hormone DeficiencyTreatment
NCT00519558Growth Hormone Deficiency in Adults (GHDA)Treatment
NCT00294619Treatment of Adults With Growth Hormone DeficiencyTreatment
NCT00191360Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Patients With Growth Hormone DeficiencyTreatment
NCT00184743Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)Treatment
NCT00184678Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone DeficiencyTreatment
NCT00184730Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)Treatment